ABT-202
Identifiers | |
---|---|
| |
CAS Number | 309959-34-0 |
PubChem (CID) | 39220800 |
ChemSpider | 16397614 Y |
Chemical and physical data | |
Formula | C9H13N3 |
Molar mass | 163.219 |
3D model (Jmol) | Interactive image |
| |
| |
(verify) |
ABT-202 is a drug developed by Abbott, which acts as an agonist at neural nicotinic acetylcholine receptors and has been researched for use as an analgesic, although it has not passed clinical trials.[1][2][3]
References
- ↑ Jain, K. K. (2004). "Modulators of nicotinic acetylcholine receptors as analgesics". Current opinion in investigational drugs (London, England : 2000). 5 (1): 76–81. PMID 14983978.
- ↑ Romanelli, M.; Gratteri, P.; Guandalini, L.; Martini, E.; Bonaccini, C.; Gualtieri, F. (2007). "Central nicotinic receptors: structure, function, ligands, and therapeutic potential". ChemMedChem. 2 (6): 746–767. doi:10.1002/cmdc.200600207. PMID 17295372.
- ↑ Xu, Naxing; Kim, Grace E.; Gregg, Hope; Wagdy, Azza; Swaine, Brendan A.; Chang, Min S.; El-Shourbagy, Tawakol A. (September 2004). "Automated 96-well liquid–liquid back extraction liquid chromatography–tandem mass spectrometry method for the determination of ABT-202 in human plasma". Journal of Pharmaceutical and Biomedical Analysis. 36 (1): 189–195. doi:10.1016/j.jpba.2004.05.013.
Opioids | |||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Paracetamol-type |
| ||||||||||||||||||||||||||||||
NSAIDs |
| ||||||||||||||||||||||||||||||
Cannabinoids | |||||||||||||||||||||||||||||||
Ion channel modulators |
| ||||||||||||||||||||||||||||||
Myorelaxants | |||||||||||||||||||||||||||||||
Others | |||||||||||||||||||||||||||||||
|
This article is issued from Wikipedia - version of the 4/2/2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.